(Q48469829)
Statements
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma (English)
S S Legha
S Ring
A Bedikian
A C Buzaid
C Plager
N Papadopoulos